Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$40.97 - $43.33 $3.26 Million - $3.45 Million
-79,590 Reduced 25.91%
227,635 $9.64 Million
Q4 2023

Feb 14, 2024

BUY
$32.77 - $42.31 $95,557 - $123,375
2,916 Added 0.96%
307,225 $12.8 Million
Q3 2023

Nov 14, 2023

BUY
$35.46 - $40.13 $2.63 Million - $2.97 Million
74,054 Added 32.16%
304,309 $11.5 Million
Q2 2023

Aug 14, 2023

BUY
$24.24 - $40.97 $564,598 - $954,273
23,292 Added 11.25%
230,255 $8.73 Million
Q1 2023

May 15, 2023

SELL
$23.0 - $31.59 $1.66 Million - $2.28 Million
-72,070 Reduced 25.83%
206,963 $5.03 Million
Q4 2022

Feb 14, 2023

BUY
$27.6 - $32.99 $2.65 Million - $3.16 Million
95,893 Added 52.36%
279,033 $8.1 Million
Q3 2022

Nov 14, 2022

BUY
$28.74 - $39.9 $743,360 - $1.03 Million
25,865 Added 16.45%
183,140 $5.49 Million
Q2 2022

Aug 15, 2022

SELL
$35.0 - $43.59 $2.29 Million - $2.86 Million
-65,568 Reduced 29.42%
157,275 $5.69 Million
Q1 2022

May 16, 2022

BUY
$43.12 - $50.3 $3.08 Million - $3.6 Million
71,489 Added 47.23%
222,843 $9.64 Million
Q4 2021

Feb 14, 2022

SELL
$47.6 - $65.0 $1.72 Million - $2.34 Million
-36,060 Reduced 19.24%
151,354 $7.59 Million
Q3 2021

Nov 15, 2021

BUY
$62.34 - $73.38 $222,429 - $261,819
3,568 Added 1.94%
187,414 $11.9 Million
Q2 2021

Aug 16, 2021

BUY
$70.26 - $76.64 $7.02 Million - $7.66 Million
99,945 Added 119.12%
183,846 $13.2 Million
Q1 2021

May 17, 2021

BUY
$70.48 - $79.95 $122,353 - $138,793
1,736 Added 2.11%
83,901 $6.19 Million
Q4 2020

Feb 12, 2021

BUY
$54.4 - $73.42 $3.74 Million - $5.04 Million
68,710 Added 510.67%
82,165 $6.03 Million
Q3 2020

Nov 16, 2020

BUY
$54.41 - $68.2 $75,085 - $94,116
1,380 Added 11.43%
13,455 $738,000
Q2 2020

Aug 14, 2020

SELL
$61.66 - $70.16 $301,024 - $342,521
-4,882 Reduced 28.79%
12,075 $803,000
Q1 2020

May 15, 2020

BUY
$59.35 - $88.73 $89,025 - $133,095
1,500 Added 9.7%
16,957 $1.04 Million
Q4 2019

Feb 14, 2020

BUY
$74.18 - $97.92 $22,254 - $29,376
300 Added 1.98%
15,457 $1.36 Million
Q2 2019

Aug 14, 2019

BUY
$83.92 - $108.88 $163,644 - $212,316
1,950 Added 14.76%
15,157 $1.3 Million
Q1 2019

May 15, 2019

BUY
$85.97 - $108.09 $1.14 Million - $1.43 Million
13,207 New
13,207 $1.43 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.